These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18804501)

  • 1. CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.
    Páldy E; Bereczki E; Sántha M; Wenger T; Borsodi A; Zimmer A; Benyhe S
    Neurochem Int; 2008 Dec; 53(6-8):309-16. PubMed ID: 18804501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors.
    Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
    Neurochem Int; 2008 Jan; 52(1-2):321-8. PubMed ID: 17698254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors.
    Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E
    Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.
    Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
    Acta Biol Hung; 2007; 58 Suppl():113-29. PubMed ID: 18297798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
    Cinar R; Szücs M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
    Cox ML; Haller VL; Welch SP
    Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
    Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
    Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
    Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
    Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the CB1 cannabinoid receptor inverse agonist AM251 on food intake and body weight in mice lacking mu-opioid receptors.
    Chen RZ; Frassetto A; Fong TM
    Brain Res; 2006 Sep; 1108(1):176-8. PubMed ID: 16828068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.
    Curto-Reyes V; Llames S; Hidalgo A; Menéndez L; Baamonde A
    Br J Pharmacol; 2010 Jun; 160(3):561-73. PubMed ID: 20233215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat.
    Scott DA; Wright CE; Angus JA
    Pain; 2004 May; 109(1-2):124-31. PubMed ID: 15082134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
    Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
    Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis.
    Hasanein P
    Neurosci Lett; 2009 Oct; 462(3):230-4. PubMed ID: 19616063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CB(2) cannabinoid receptor regulates human sperm cell motility.
    Agirregoitia E; Carracedo A; Subirán N; Valdivia A; Agirregoitia N; Peralta L; Velasco G; Irazusta J
    Fertil Steril; 2010 Mar; 93(5):1378-87. PubMed ID: 19328464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.
    Duncan M; Millns P; Smart D; Wright JE; Kendall DA; Ralevic V
    Br J Pharmacol; 2004 Jun; 142(3):509-18. PubMed ID: 15148262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies.
    Seely KA; Brents LK; Franks LN; Rajasekaran M; Zimmerman SM; Fantegrossi WE; Prather PL
    Neuropharmacology; 2012 Oct; 63(5):905-15. PubMed ID: 22771770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
    Nackley AG; Makriyannis A; Hohmann AG
    Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist.
    Guarna M; Bartolini A; Ghelardini C; Galeotti N; Bracci L; Stefano GB; Bianchi E
    Brain Res Mol Brain Res; 2003 Nov; 119(1):100-10. PubMed ID: 14597234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.